These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22100680)

  • 1. Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate "rosy" prophecy.
    Wykrzykowska JJ; Onuma Y; Serruys PW
    EuroIntervention; 2009 Dec; 5 Suppl F():F7-8. PubMed ID: 22100680
    [No Abstract]   [Full Text] [Related]  

  • 2. Engineering a bioresorbable stent: REVA programme update.
    Pollman MJ
    EuroIntervention; 2009 Dec; 5 Suppl F():F54-7. PubMed ID: 22100677
    [No Abstract]   [Full Text] [Related]  

  • 3. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stents: safe but not sufficient.
    Vogel RA
    JACC Cardiovasc Interv; 2009 Jun; 2(6):513-4. PubMed ID: 19539254
    [No Abstract]   [Full Text] [Related]  

  • 5. Nevo stent: a successful stent makeover.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):52-3. PubMed ID: 21181969
    [No Abstract]   [Full Text] [Related]  

  • 6. Rotational atherectomy with drug-eluting stents: a necessary technique in the current era.
    Lozano I; Rondan J; Avanzas P
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):160; author reply 161. PubMed ID: 21069801
    [No Abstract]   [Full Text] [Related]  

  • 7. Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds?
    Bangalore S; Mauri L
    EuroIntervention; 2009 Dec; 5 Suppl F():F43-8. PubMed ID: 22100675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCI in small vessels: the case for a drug-coated balloon based intervention.
    Zeymer U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K57-60. PubMed ID: 22027729
    [No Abstract]   [Full Text] [Related]  

  • 9. Stent thrombosis--risk assessment and prevention.
    Motovska Z; Knot J; Widimsky P
    Cardiovasc Ther; 2010 Oct; 28(5):e92-100. PubMed ID: 20553282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEVO™: a new generation of sirolimus-eluting coronary stent.
    Falotico R; Parker T; Grishaber R; Price S; Cohen SA; Rogers C
    EuroIntervention; 2009 Dec; 5 Suppl F():F88-93. PubMed ID: 22100684
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoatherosclerosis: fooling mother nature.
    King SB
    JACC Cardiovasc Interv; 2014 May; 7(5):579-80. PubMed ID: 24852808
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atheroma and coronary bifurcations: before and after stenting.
    Yazdani SK; Nakano M; Otsuka F; Kolodgie FD; Virmani R
    EuroIntervention; 2010 Dec; 6 Suppl J():J24-30. PubMed ID: 21930487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 15. Everolimus-eluting bioabsorbable stent--Abbot Vascular programme.
    Onuma Y; Piazza N; Ormiston JA; Serruys PW
    EuroIntervention; 2009 Dec; 5 Suppl F():F98-F102. PubMed ID: 22100687
    [No Abstract]   [Full Text] [Related]  

  • 16. Left main and high-risk PCI: what, exactly, is it high risk for?
    Safian RD
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):952-3. PubMed ID: 21598347
    [No Abstract]   [Full Text] [Related]  

  • 17. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral sirolimus after bare metal stent implantation: a glimpse to the future.
    Mieres J
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):158-9. PubMed ID: 20931667
    [No Abstract]   [Full Text] [Related]  

  • 19. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
    Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stent expansion as a mechanical parameter to predict late stent patency: back to the basics.
    Honda Y; Fitzgerald PJ
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1276-8. PubMed ID: 20129556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.